“This is the golden age of neuro right now and we’re smack dab in the middle of it,” said Greg Alden, DBC’s President and CEO, in a recent interview with the Maryland Department of Commerce. They discussed:
“If the science is hard, the tools shouldn’t be,” said Alden. “The goal is to create an environment where researchers will collaborate and really decode information together—and do so in a repeatable way.”
Read the full interview here: https://business.maryland.gov/blog/diagnostic-biochips-is-probing-into-the-science-of-neurological-disorders